Refractory headache: Historical perspective, need, and purposes for an operational definition

被引:18
作者
Schulman, Elliott A. [1 ]
Brahin, Eric J. [2 ]
机构
[1] Lankenau Inst Med Res, Wynnewood, PA 19096 USA
[2] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA
来源
HEADACHE | 2008年 / 48卷 / 06期
关键词
refractory; intractable; headache; migraine; definition; history;
D O I
10.1111/j.1526-4610.2008.01135.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The study of migraine has yielded many benefits for headache patients. Little research, however, has been performed on refractory migraine (RM) headache, a term often used interchangeably with intractable migraine. This may be a consequence of a lack of a well-accepted definition. In a survey performed by the Refractory Headache Special Interest Section (RHSIS) on the American Headache Society (AHS) in 2006, 58% of the members agreed that a definition for refractory headache should be added to the International Classification of Headache Disorders-2. A PubMed search identified 21 articles that defined refractory or intractable headache/migraine. Sixteen (76%) defined the term "refractory" and 5 (24%) defined the term "intractable." Many of these definitions did not address the need for an adequate trial of a preventive medicine, disability, and medication overuse. An operational definition will allow us to better characterize the disorder, address unmet medical needs, and identify the most effective treatments. RHSIS of the AHS has proposed a definition of RM. It is our hope that this definition will spur interest in this entity and will lead to further research in the area.
引用
收藏
页码:770 / 777
页数:8
相关论文
共 45 条
[1]  
*AM HEAD SOC, MIN REFR HEAD SPEC I
[2]  
[Anonymous], [No title captured]
[3]   Surgical treatment of patients with refractory migraine headaches and intranasal contact points [J].
Behin, F ;
Behin, B ;
Bigal, ME ;
Lipton, RB .
CEPHALALGIA, 2005, 25 (06) :439-443
[4]   Modifiable risk factors for migraine progression (or for chronic daily headaches) - Clinical lessons [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
HEADACHE, 2006, 46 :S144-S146
[5]   Epidemiology of chronic daily headache in the general population [J].
Castillo, J ;
Muñoz, P ;
Guitera, V ;
Pascual, J .
HEADACHE, 1999, 39 (03) :190-196
[6]   Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication [J].
Chayasirisobhon, S .
HEADACHE, 2006, 46 (05) :788-793
[7]   Botox therapy for refractory chronic migraine [J].
Conway, S ;
Delplanche, C ;
Crowder, J ;
Rothrock, J .
HEADACHE, 2005, 45 (04) :355-357
[8]   Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial [J].
Diener, Hans-Christoph ;
Agosti, Reto ;
Allais, Gianni ;
Bergmans, Paul ;
Bussone, Gennaro ;
Davies, Brendan ;
Ertas, Mustafa ;
Lanteri-Minet, Michel ;
Reuter, Uwe ;
Del Rio, Margarita Sdnchez ;
Schoenen, Jean ;
Schwalen, Susanne ;
van Oene, Joop .
LANCET NEUROLOGY, 2007, 6 (12) :1054-1062
[9]   Consensus statement:: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine [J].
Dodick, D ;
Lipton, RB ;
Martin, V ;
Papademetriou, V ;
Rosamond, W ;
MaassenVanDenBrink, A ;
Loutfi, H ;
Welch, KM ;
Goadsby, PJ ;
Hahn, S ;
Hutchinson, S ;
Matchar, D ;
Silberstein, S ;
Smith, TR ;
Purdy, RA ;
Saiers, J .
HEADACHE, 2004, 44 (05) :414-425
[10]   Gamma knife treatment for refractory cluster headache:: prospective open trial [J].
Donnet, A ;
Valade, D ;
Régis, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (02) :218-221